Compared to hypofractionated radiotherapy, SBRT improves short-term but not long-term QoL in patients with inoperable stage I ...

A majority — eight members — voted that women who have tested negative for hepatitis B should consult with clinicians on when ...

The results of the 2025 Medicine and Pediatric Specialties Match followed the same patterns seen in recent years for both ...

Dr S. Shahzad Mustafa discusses three FDA approved medications for chronic spontaneous urticaria and the need to tailor ...

A deep analysis of semaglutide’s phase 3 AD trials shows no cognitive or functional benefit despite biomarker gains, yet ...

A retrospective real-world study strengthens evidence that early, sustained treatment with the antiamyloid lecanemab can slow ...

AI-generated avatars allow you to interact with deceased loved ones on demand — potentially for decades. A healthy grieving ...

Lisocabtagene maraleucel (liso-cel) is now the only CD19-directed chimeric antigen receptor (CAR) T-cell therapy approved for MZL. The approval marks liso-cel’s fifth indication, the most of any ...

A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from ...

Measurements of epigenetic age can highlight modifiable risk factors for pregnancy complications and later illness.

It’s a bit of a Wild West out there when it comes to in vitro fertilization (IVF) tests and treatments. Many new tests and ...

Early evidence links some Alzheimer’s Disease medications to small cognitive gains in children with autism and low IQ, ...